Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
ZOLMITRIPTAN Orally Disintegrating Tablets, for oral use These highlights do not include all the information needed to use zolmitriptan orally disintegrating tablets safely and effectively. See full prescribing information for zolmitriptan orally disintegrating tablets. Initial U.S. Approval: 1997
Medication labelWhy this: Advisory · dailymed-prescription
Zolmitriptan orally disintegrating tablets are indicated for the acute treatment of migraine with or without aura in adults. Limitations of Use Only use zolmitriptan orally disintegrating tablets are if a clear diagnosis of migraine has been established. If a patient has no response to zolmitriptan orally disintegrating tablets are treatment for the first migraine attack, reconsider the diagnosis of migraine before zolmitriptan orally disintegrating tablets are administered to treat any subsequent attacks. Zolmitriptan orally disintegrating tablets are not indicated for the prevention of migraine attacks. Safety and effectiveness of zolmitriptan orally disintegrating tablets have not been established for cluster headache.
- generic_name
- zolmitriptan
- product_names
- Zolmitriptan
- ndc
- 42291-998, 42291-998-06, 42291-999, 42291-999-03
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en